The Jakarta Post reports.

Kaiser Health News, an editorially independent information service, is a scheduled system of the Kaiser Family Foundation, a nonpartisan healthcare policy research company unaffiliated with Kaiser Permanente.. ASEAN members sign fresh action plan to fight dengue Users of the Association of Southeast Asian Countries on Wednesday as part of an event marking ASEAN Dengue Time signed a new action plan targeted at fighting dengue in your community, the Jakarta Post reports. The Jakarta Demand Actions on the Control and Avoidance of Dengue phone calls upon stakeholders in the region to strengthen regional cooperation on dengue prevention, to combat the disease in sustainable ways, and promote inter-sectoral collaboration, the newspaper writes .In conclusion, patients with isolated, symptomatic superficial-vein thrombosis in the legs are in considerable risk for symptomatic thromboembolic complications. Fondaparinux administered at a dose of 2.5 mg once daily for 45 times is effective and applicable for the treatment of such patients widely.. Senthil Senniappan, M.D., Sanda Alexandrescu, M.D., Nina Tatevian, M.D., Pratik Shah, M.D., Ved Arya, M.D., Sarah Flanagan, Ph.D., Sian Ellard, Ph.D., Dyanne Rampling, F.We.B.M.S., Michael Ashworth, M.D., Robert E. Dark brown, M.D., and Khalid Hussain, M.D.: Short Survey: Sirolimus Therapy in Infants with Serious Hyperinsulinemic Hypoglycemia Hyperinsulinemic hypoglycemia, a major cause of severe hypoglycemia through the neonatal period, is definitely seen as a inappropriate insulin secretion from pancreatic beta cells in the current presence of low blood sugar levels.1 The condition may derive from defects in crucial genes involved in the regulation of insulin secretion from beta cells, including ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, HNF4A, HNF1A, and UCP2.1,2 Two major histologic subtypes have been described: diffuse and focal.3 Mutations in ABCC8 and KCNJ11 are connected with severe hyperinsulinemic hypoglycemia that is unresponsive to treatment with diazoxide and octreotide.1 The only treatment choice currently available for sufferers with medically unresponsive types of diffuse hyperinsulinemic hypoglycemia is a subtotal pancreatectomy, where 95 to 98 percent of insulin-secreting cells are physically removed to ease the severe hypoglycemia.